Does PATISIRAN Cause Infusion site swelling? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Infusion site swelling have been filed in association with PATISIRAN (Onpattro). This represents 1.1% of all adverse event reports for PATISIRAN.
29
Reports of Infusion site swelling with PATISIRAN
1.1%
of all PATISIRAN reports
0
Deaths
15
Hospitalizations
How Dangerous Is Infusion site swelling From PATISIRAN?
Of the 29 reports, 15 (51.7%) required hospitalization.
Is Infusion site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PATISIRAN. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does PATISIRAN Cause?
Death (250)
Product dose omission issue (175)
Fatigue (165)
Infusion related reaction (134)
Hospitalisation (127)
Asthenia (108)
Fall (107)
Intentional dose omission (107)
Cardiac failure (95)
Dyspnoea (87)
What Other Drugs Cause Infusion site swelling?
HUMAN IMMUNOGLOBULIN G (1,772)
TREPROSTINIL (1,686)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (241)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (194)
AMBRISENTAN (173)
INFLIXIMAB-DYYB (100)
INFLIXIMAB (98)
MACITENTAN (96)
VEDOLIZUMAB (57)
FOSCARBIDOPA\FOSLEVODOPA (55)
Which PATISIRAN Alternatives Have Lower Infusion site swelling Risk?
PATISIRAN vs PAXIL
PATISIRAN vs PAZOPANIB
PATISIRAN vs PEANUT
PATISIRAN vs PEG INTERFERON
PATISIRAN vs PEG-INTERFERON ALFA 2A